[Optimum heart rate - the current goal of cardiovascular therapy. Position statement of the Polish Cardiac Society Working Group on Cardiovascular Drug Therapy].
Katedra Kardiologii, Uniwersytet Medyczny w Łodzi, 91–347 Łódź. kasprzak@ptkardio.pl
Jarosław D
JD
Kasprzak
Janina
J
Stępińska
Beata
B
Wożakowska Kapłon
Jarosław
J
Drożdż
Stefan
S
Grajek
Grzegorz
G
Opolski
Andrzej
A
Rynkiewicz
Andrzej
A
Tykarski
Krzysztof J
KJ
Filipiak
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000638:Amiodarone / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000150:complications / Q000628:therapy*; D001552:Benzazepines / Q000627:therapeutic use; D004077:Digoxin / Q000627:therapeutic use; D004110:Diltiazem / Q000627:therapeutic use; D006331:Heart Diseases / Q000150:complications; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000150:complications; D000077550:Ivabradine; D014700:Verapamil / Q000627:therapeutic use
D000318:Adrenergic beta-Agonists; D000889:Anti-Arrhythmia Agents; D001552:Benzazepines; D000077550:Ivabradine; D004077:Digoxin; D014700:Verapamil; D004110:Diltiazem; D000638:Amiodarone